Combined Use of Superficial Keratectomy and Subconjunctival Bevacizumab Injection for Corneal Neovascularization

• DOI: 10.1097/ico.0b013e31817c41e3
• Publication Date: 2008-09-19T07:15:20Z
• Authors: Cynthia Xin-ya Qian; Irit Bahar; Eliya Levinger; David Rootman
• Keywords: Corneal Neovascularization

Purpose: To report the effect of superficial keratectomy combined with subconjunctival bevacizumab injection in 2 cases corneal neovascularization (NV). Methods: An interventional case series was undertaken on patients NV: 1 due to sclerokeratitis secondary rheumatoid arthritis and other Terrien marginal degeneration. Both underwent (2.5 mg/0.1 mL). Results: Corneal NV regressed surgical removal showed no signs recurrence after 3 months follow-up. reported dramatic subjective improvement their vision within 1-2 weeks. Best corrected visual acuity improved patient. Conclusion: The combination may offer a new strategy for treatment NV.